Literature DB >> 12622254

Influenza virus variants with reduced susceptibility to inhibition by a polyphenol extract from Geranium sanguineum L.

J Serkedjieva1.   

Abstract

A polyphenol extract obtained from the Bulgarian medicinal plant Geranium sanguineum L. (PC) inhibited influenza virus reproduction in vitro, in ovo and in vivo. The inhibitory activity of the plant preparation was proved to be selective and specific. Two variants of the virus A/chicken/Germany/34, strain Rostock (H7N1) (A/Rostock) with reduced drug sensitivity were selected by following passages in chicken embryo fibroblast (CEF) cells in the presence of inhibitory concentrations of the substance and by subsequent purification of resistant plaques (A/Rostock-R). PC affected to a lesser extent the biological activity and the infectivity of the resistant variants compared to the sensitive parent. The lower susceptibility of the variants was consistently observed in contact assay, ELISA, cytopathogenic effect reduction, plaque reduction and infectious virus yield reduction assays. Virus-specific protein synthesis in CEF cells infected with the resistant variants, determined by 35S-labelling and following SDS-PAGE, was also less sensitive to inhibition with PC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622254

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  7 in total

Review 1.  Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.

Authors:  Rachana Singh; Pradhyumna Kumar Singh; Rajnish Kumar; Md Tanvir Kabir; Mohammad Amjad Kamal; Abdur Rauf; Ghadeer M Albadrani; Amany A Sayed; Shaker A Mousa; Mohamed M Abdel-Daim; Md Sahab Uddin
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

2.  Potent and Selective Activity against Human Immunodeficiency Virus 1 (HIV-1) of Thymelaea hirsuta Extracts.

Authors:  Giuseppina Sanna; Silvia Madeddu; Giuseppe Murgia; Gabriele Serreli; Michela Begala; Pierluigi Caboni; Alessandra Incani; Gianluigi Franci; Marilena Galdiero; Gabriele Giliberti
Journal:  Viruses       Date:  2020-06-19       Impact factor: 5.048

3.  Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.

Authors:  Namisha Sharma; Mehanathan Muthamilarasan; Ashish Prasad; Manoj Prasad
Journal:  Genomics       Date:  2020-07-24       Impact factor: 5.736

4.  Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins.

Authors:  Aarthi Sundararajan; Radha Ganapathy; Lifang Huan; John R Dunlap; Richard J Webby; Girish J Kotwal; Mark Y Sangster
Journal:  Antiviral Res       Date:  2010-07-14       Impact factor: 5.970

Review 5.  Licorice (Glycyrrhiza glabra) Extracts-Suitable Pharmacological Interventions for COVID-19? A Review.

Authors:  Joji Abraham; Singarayer Florentine
Journal:  Plants (Basel)       Date:  2021-11-26

Review 6.  Potential Benefits of Antiviral African Medicinal Plants in the Management of Viral Infections: Systematic Review.

Authors:  Tamirat Bekele Beressa; Serawit Deyno; Andrew G Mtewa; Namuli Aidah; Naasson Tuyiringire; Ben Lukubye; Anke Weisheit; Casim Umba Tolo; Patrick Engeu Ogwang
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

Review 7.  Antiviral potentials of medicinal plants.

Authors:  Muhammad Mukhtar; Mohammad Arshad; Mahmood Ahmad; Roger J Pomerantz; Brian Wigdahl; Zahida Parveen
Journal:  Virus Res       Date:  2007-11-05       Impact factor: 3.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.